Literature DB >> 2118856

Correlation between peripheral CA-125 levels and ovarian activity.

A Zweers1, J De Boever, R Serreyn, D Vandekerckhove.   

Abstract

Serum CA-125 concentrations were measured at three different times in normal cycles, pill-suppressed cycles, and cycles stimulated for intrauterine insemination (IUI) or oocyte retrieval, i.e., (1) during the first half of the cycle, (2) at midcycle or at the moment of oocyte retrieval, and (3) the second half of the cycle. Significant variations of serum CA-125 concentrations were not seen during the cycle in normally cycling women or in women taking oral contraceptives: mean +/- SD 28.9 +/- 13.3 U/mL and 26.9 +/- 11.3 U/mL, respectively. In patients stimulated for in vitro fertilization, luteal phase CA-125 levels (60.6 +/- 38 U/mL) were significantly higher than during stimulation (21.5 +/- 5.9 U/mL) or at oocyte retrieval (19.6 +/- 6.4 U/mL). In stimulated cycles for IUI, without laparoscopy or follicular puncture, a comparable rise of CA-125 was observed in the luteal phase (49.6 +/- 37.8 U/mL). However, in patients undergoing laparoscopic sterilization, serum CA-125 concentrations before and after laparoscopy were not significantly different (22.8 +/- 6.3 U/mL and 25 +/- 4.2 U/mL, respectively).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118856     DOI: 10.1016/s0015-0282(16)53753-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.

Authors:  A M Paoletti; G G Serra; V Mais; S Ajossa; S Guerriero; M Orrù; G B Melis
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

2.  Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women.

Authors:  Emanuela Anastasi; Teresa Granato; Giulia Giovanna Marchei; Valentina Viggiani; Barbara Colaprisca; Sara Comploj; Maria Gabriella Reale; Luigi Frati; Cecilia Midulla
Journal:  Tumour Biol       Date:  2010-05-20

3.  Relationship between serum CA 125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity.

Authors:  G Ozakşit; N O Turhan; H Oral; N Doğu; O Gökmen
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

4.  Significance of the serum CA-125 level in intrauterine insemination cycles.

Authors:  Seung Ah Choe; Seung-Yup Ku; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim; Young Min Choi; Jung Gu Kim; Shin Young Moon
Journal:  Clin Exp Reprod Med       Date:  2011-09-30

5.  How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis.

Authors:  Marco Aurelio Pinho Oliveira; Thiers Soares Raymundo; Leila Cristina Soares; Thiago Rodrigues Dantas Pereira; Alessandra Viviane Evangelista Demôro
Journal:  Biomed Res Int       Date:  2017-06-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.